A F ASTERAND DR. REBECCA CAFFREY ASTERAND DR. REBECCA CAFFREY
Asterand's Dr. Rebecca Caffrey. (PRNewsFoto)[TC]
DETROIT, MI USA
DETROIT, April 15 /PRNewswire/ -- Asterand, the Detroit-based provider of
human tissue services has appointed Rebecca Caffrey, Ph.D. as Business
Development manager to promote the experimental pathology services offered by
the company. She comes to Asterand from Ciphergen where she served as
Business Development and Product Manager, and has experience in project
management, high-throughput proteomics technologies, and strategic alliance
(Photo: http://www.newscom.com/cgi-bin/prnh/20050415/DEF008 )
"We are very excited to have Rebecca on our team," says Mike Null,
Asterand's Vice President of Sales and Marketing. "She brings with her a
wealth of technical knowledge, an enthusiasm for the research services she
will be providing, and a commitment to building strong relationships with
customers. She is a great asset to our business development endeavors."
Dr. Caffrey will work with pharmaceutical and biotechnology wishing to
outsource specialized research projects, requiring the pathology expertise
provided by Asterand. The company's services are focused on
immunohistochemistry screening of therapeutic monoclonal antibodies, including
human antibodies for human tissue cross-reactivity, protein localization
studies, and RNA in situ hybridization for gene expression analysis. Asterand
performs these studies on high-quality, fully validated human tissues from its
Dr. Victoria Blanc, Director of Research Services at Asterand said that
"the addition of Rebecca to our sales and services team enhances the
opportunity for Asterand to meet with scientists developing projects. Her
expertise will assist in working through the scientific details and
requirements that produce effective and results-driven experiments. Her
experience in proteomics, as well, nicely complements my own in genomics."
Asterand is the leading provider of human tissue for genomic and proteomic
research. The company acquires donated samples from a world wide network of
collaborating hospitals and clinics. These samples together with associated
data and pathology reports are made available to commercial drug discovery
companies as well as researchers at academic institutions.
Asterand supplies tissues in a variety of formats including fresh, frozen
and fixed as well as derivative products such as tissue microarrays, RNA and
DNA. The company also carries out a wide range of applied research projects
on behalf of clients.
For more information, contact Dr. Victoria Blanc at 313-263-0960 or visit
Asterand's website at http://www.asterand.com .